Your Health, We Care
Avoid co-administration of ixazomib with strong CYP3A inducers (e.g., rifampicin, phenytoin sodium, carbamazepine, and St. John's wort).
from FDA,2024.07
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unres···【more】
Release date：2026-01-08Recommended：26
Ixazomib is a proteasome inhibitor, and its mechanism of action helps kill cance···【more】
Release date：2026-01-08Recommended：31
Ixazomib Citrate is approved for use in combination with lenalidomide and dexame···【more】
Release date：2026-01-08Recommended：28
